Physician profile
David H Dunkle
NPI 1053468041
$1,120.84
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $279 · 2021: $22.10 · 2023: $99.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $275.81 | 2019-2020 | |
| Novo Nordisk INC | $138.24 | 2019-2020 | |
| Aquestive Therapeutics, INC. | $125.00 | 2019 | |
| Glaxosmithkline, LLC. | $113.06 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $108.21 | 2019 | |
| Dexcom, INC. | $99.03 | 2023 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $61.05 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.02 | 2019 | |
| Stryker Corporation | $31.08 | 2019 | |
| Sandoz INC. | $22.10 | 2021 | |
| Aytu Biopharma, INC. | $19.38 | 2019 | |
| Abbvie INC. | $14.98 | 2019 | |
| Amgen INC. | $13.44 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.01 | 2019 | |
| Abbott Laboratories | $12.40 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $12.11 | 2019 | |
| Pfizer INC. | $11.69 | 2019 | |
| Merck Sharp & Dohme LLC | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dunkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.